Excellent post tada. You and others have provided perspectives that help a guy like me understand and see possibilities.

I do think the deal is exceptionally good for Hepalink. They took control of RVX at bargain basement prices and they did not see the IP slip away. They now effectively control that IP no matter which way the FA goes. Dart receives an obvious benefit in terms of de-risking, freeing up capital and yet maintaining his shares in a potential blockbuster. As has been mentioned RVX benefits by solving the LOC problem and protecting IP. So both companies benefit. Also, insolvency has been staved off for the next few months.

In my opinion this was obviously not a strategic deal (please don't laugh too hard here..actually I can't believe I wrote that and I am chuckling now at myself). If Don was having serious discussions with one or more LOI partners and if he could have seen light on this pre Dec 26th he would not have done this Hepa deal even if there was short term payable issues...nobody sells their company under these conditions for such a low price unless there was no hope. Remember the BoD had to approve this. So there is a bit of breathing space now before the next stage but the attention to the next round of financing must be occupying every moment of Don and the BoD's time.

There is one possibility (probably a few) and that is that given that Hepa is a producing pharma company their control of RVX could spark interest from a BP. I don't think that AZ or Pfizer or others would like to see Hepa move into the CVD, DM, etc spaces for virtually no significant investment to take control of potentially blockbuster science. Beside, if the Hepa deal goes through I'm sure they will make BP pay dearly because they do not have a vice squeezing their financial temples.

Tada, you raise a very interesting point regarding the possibility that a few BPs could be holding RVX up to 5%. This sure raises possibilities.

I'd sure like to know Don and his board's next 5 chess moves in this game. Who knows what deals are being discussed.

So I guess my great disappointment is that I really believed that we/RVX would receive some sort of CVR deal at good prices for rvx-208 alone (e.g. $25 opening and moving up from there) through the various milestones based on the global market size and growth, particularly with the growth in the DM and CVD markets because of the continuing obesity crisis. Well, it didn't happen.

At least we have liquidity as long as the TSX allows the listing to continue under this situation. I guess we'll know soon.

I retain my RVX shares as well as my Zenith shares. So there remains the potential for royalities in the long term. Who knows, if zen3694 is actually having an impact on mCRPC there could be a big gain and yet Don has not created liquidity on this company.

Would it be fair to assume that when the deal goes through that it will then become very easy to achieve a 51% vote on any motion theyr put through?

GLTA

Toinv